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The arterivirus family (order Nidovirales) of single-stranded, positive-sense RNA viruses includes
porcine respiratory and reproductive syndrome virus and equine arteritis virus (EAV). Their
replicative enzymes are translated from their genomic RNA, while their seven structural proteins
are encoded by a set of small, partially overlapping genes in the genomic 39-proximal region. The
latter are expressed via synthesis of a set of subgenomic mRNAs that, in general, are functionally
monocistronic (except for a bicistronic mRNA encoding the E and GP2 proteins). ORF5, which
encodes the major glycoprotein GP5, has been used extensively for phylogenetic analyses.
However, an in-depth computational analysis now reveals the arterivirus-wide conservation of an
additional AUG-initiated ORF, here termed ORF5a, that overlaps the 59 end of ORF5. The pattern
of substitutions across sequence alignments indicated that ORF5a is subject to functional
constraints at the amino acid level, while an analysis of substitutions at synonymous sites in ORF5
revealed a greatly reduced frequency of substitution in the portion of ORF5 that is overlapped by
ORF5a. The 43–64 aa ORF5a protein and GP5 are probably expressed from the same
subgenomic mRNA, via a translation initiation mechanism involving leaky ribosomal scanning.
Inactivation of ORF5a expression by reverse genetics yielded a severely crippled EAV mutant,
which displayed lower titres and a tiny plaque phenotype. These defects, which could be partially
complemented in ORF5a-expressing cells, indicate that the novel protein, which may be the
eighth structural protein of arteriviruses, is expressed and important for arterivirus infection.
INTRODUCTION
Arteriviruses are enveloped viruses (approx. 60 nm dia-
meter) with a 13–16 kb positive-sense RNA genome. The
family Arteriviridae (Snijder & Meulenberg, 1998; Snijder &
Spaan, 2006) currently comprises four members: equine
arteritis virus (EAV, the family prototype), lactate dehy-
drogenase-elevating virus (LDV) of mice, porcine repro-
ductive and respiratory syndrome virus (PRRSV) and
simian haemorrhagic fever virus (SHFV). The conse-
quences of arterivirus infection can range from an
asymptomatic, persistent or acute infection to abortion
or lethal haemorrhagic fever (Maclachlan et al., 2007).
Three of the four arteriviruses (EAV, LDV and SHFV) were
first isolated and characterized approximately 50 years ago.
In the late 1980s, two distantly related PRRSV genotypes,
European (PRRSV-EU) and North American (PRRSV-
NA), sharing a genome-wide mean nucleotide identity of
only ~63% (Allende et al., 1999; Sua ´rez et al., 1996),
emerged simultaneously on both sides of the Atlantic
(Collins et al., 1992; Wensvoort et al., 1991). Since then,
the virus has been causing worldwide epidemics of a
previously unknown reproductive and respiratory disease
and has become one of the most economically important
swine diseases. Recently, a large outbreak of highly virulent
PRRSV affected the Asian swine industry, causing consid-
erable economic losses (Zhou & Yang, 2010).
The unification of the previously unclassified members of
the arterivirus family was the direct result of sequence
Journal of General Virology (2011), 92, 1097–1106 DOI 10.1099/vir.0.029264-0
029264 G 2011 SGM Printed in Great Britain 1097analysis of their genomes, which also revealed an intriguing
relationship with coronaviruses. Despite striking differ-
ences in genome size and virion structure, the genome
organization and expression strategy of the two groups
were found to be comparable and their key replicative
enzymes were postulated to share common ancestry (den
Boon et al., 1991). A specific feature of their genome
expression strategy is the generation of a nested set of
subgenomic (sg) mRNAs to express a variety of genes from
the 39-proximal region of the genome (Pasternak et al.,
2006; Sawicki et al., 2007). Arteriviruses and coronaviruses
were united in the order Nidovirales, which was subse-
quently expanded by the addition of the roniviruses,
toroviruses and bafiniviruses (Gorbalenya et al., 2006).
The polycistronic arterivirus genome contains at least nine
known ORFs (Fig. 1a). The replicative enzymes are
encoded by the 59-proximal replicase ORFs 1a and 1b,
yielding two long non-structural polyproteins, pp1a and
pp1ab, with the synthesis of the latter depending on a
ribosomal frameshift near the 39 end of ORF1a. The pp1a
and pp1ab precursors are processed into at least 13 mature
non-structural proteins (nsps) by three or four viral
proteinases encoded by ORF1a (Ziebuhr et al., 2000;
Fang & Snijder, 2010). In EAV, PRRSV and LDV, seven
relatively small genes have been identified in the 39-
proximal domain of the genome, positioned in the same
relative order downstream of ORF1b (Fig. 1a). In SHFV,
this region of the genome appears to contain three
additional ORFs, which may have arisen from the
duplication of ORFs 2–4 (Godeny et al., 1998) but have
not been characterized in any detail. In the other
arteriviruses, ORFs 2a–7 encode seven structural proteins:
the nucleocapsid (N) protein and six envelope proteins, the
glycoproteins (GP) GP2, GP3, GP4 and GP5, and the non-
glycosylated envelope (E) and membrane (M) proteins
(Snijder & Meulenberg, 1998; Snijder & Spaan, 2006). By
using reverse genetics to engineer gene knockouts, in both
EAV and PRRSV the expression of each of these seven
proteins was found to be critical for the production of
infectious progeny (Molenkamp et al., 2000; Wissink et al.,
2005). These experiments also revealed that cells trans-
fected with mutants lacking expression of E, GP2, GP3 or
GP4 release virus-like particles (VLPs) consisting of RNA
and the GP5, M and N proteins (Wieringa et al., 2004;
Zevenhoven-Dobbe et al., 2004). Together with the earlier
characterization of arterivirus particles (de Vries et al.,
1992; Faaberg & Plagemann, 1995; Meulenberg et al., 1995;
Snijder et al., 1999, 2003; Wieringa et al., 2004), these data
indicate that the N protein and the disulphide-linked GP5–
M heterodimer form the structural core of the virion. The
E protein and a GP2–GP3–GP4 heterotrimer are minor
virus constituents that may play a role in receptor binding
and/or virus entry (Van Breedam et al., 2010). Still, many
details of arterivirus assembly, maturation and structural
protein function remain to be elucidated.
T h eg e n o m eo r g a n i z a t i o no ft h ea r t e r i v i r u sO R F 2 – 7
region is extremely compact, with the termini of most
ORFs overlapping with neighbouring genes and with
RNA signals (transcription-regulatory sequences, TRSs)
for sg RNA synthesis commonly being embedded
in upstream ORFs (Fig. 1a). These TRSs are assumed
to operate as attenuators of negative-sense RNA
synthesis and to direct base pairing of the nascent
negative-sense strand with a complementary sequence
in the genomic 59 end (leader TRS). This results in
the generation of a 39-a n d5 9-coterminal set of
negative-sense templates that serve to produce the
arterivirus sg mRNAs (Pasternak et al., 2006; Sawicki
et al., 2007).
The arterivirus genome organization illustrates the
strong selective pressure that RNA virus genomes are
under to compress the maximum amount of coding and
regulatory information into minimal sequence space.
Overlapping coding sequences (CDSs) are particularly
common in RNA viruses, but can be difficult to detect,
especially when they are short. We have been using a
number of complementary comparative computational
approaches to systematically identify novel overlapping
genes in RNA virus genomes (Firth & Brown, 2006;
Chung et al., 2008; Firth et al., 2008; Firth & Atkins,
2009). When applied to arteriviruses, these methods
detected a novel short ORF, hereafter termed ORF5a,
overlapping the 59 end of the GP5 CDS in the +2
reading frame. Here, we present bioinformatic evidence
and experimental verification for the functional impor-
tance of ORF5a in arteriviruses.
RESULTS AND DISCUSSION
Computational analysis reveals the presence of a
small ORF overlapping the arterivirus GP5 gene
The coding potential of ORF5a was first detected in an
alignment of PRRSV-NA sequences by using the gene-
finding software MLOGD (Firth & Brown, 2006; Chung
et al., 2008). MLOGD uses nucleotide and amino acid
substitution matrices to model sequence evolution in
dual-coding, single-coding and non-coding regions. It
can be used to predict whether query ORFs are likely to
be coding sequences via an approximate likelihood-ratio
test, where the null model comprises any known CDSs
and the alternative model comprises the known CDSs and
the query ORF. When applied to the PRRSV-NA
alignment, MLOGD detected a positive coding signature
for the previously defined arterivirus CDSs and also for
ORF5a (Fig. 1b). In the National Center for
Biotechnology Information (NCBI) PRRSV-NA reference
sequence, NC_001961 (15428 nt), ORF5a covers nucleo-
tides 13778–13930 (51 codons) and therefore overlaps
the 59 end of the GP5 CDS (nucleotides 13788–14390) by
48 codons (~24% of the GP5 gene) in the +2r e a d i n g
frame. ORF5a begins immediately 39 of the ORF4
termination codon and 10 nt 59 of the ORF5 initiation
codon (Fig. 2b).
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other arteriviruses, EAV (Fig. 2a), LDV and SHFV, and
again MLOGD detected a positive coding signature for
ORF5a using sequence alignments of PRRSV-EU, EAV and
LDV. Incidentally, the presence of this ORF in EAV,
though not its bioinformatic coding signature, had
Fig. 1. (a) EAV genome organization and expression. The positions of the ORFs encoding the seven known structural proteins
and the newly discovered ORF5a are indicated. ORF5a slightly overlaps with the GP4 gene and largely overlaps with the GP5
gene. Small grey boxes indicate the positions of the TRS that direct sg RNA synthesis and serve as junction sequences for the
59 common leader sequence of arterivirus mRNAs. (b) Maps of the ORF5a/ORF5 region of the genomes of representative
arterivirus sequences (see Fig. 2b for GenBank accession numbers). For EAV and the two PRRSV genotypes, plots are shown
for several coding-potential statistics in a 15-codon sliding window. The top and middle panels illustrate the degree of
conservation at synonymous sites within the GP5 CDS: the top panel depicts the probability that the degree of conservation
within a given window could be obtained under a null model of neutral evolution at synonymous sites, while the middle panel
depicts the absolute amount of conservation as represented by the ratio of the observed number of substitutions within a given
window to the number expected under the null model. Scores below the dashed line correspond to more conserved regions and
are indicative of overlapping functional elements, either coding or non-coding. Owing to the huge quantity of GP5 sequence
data (8344 sequences) available for the PRRSV-NA plot, the formal P values for this analysis are extremely small for the
conserved 59 region. The bottom panel depicts the MLOGD coding potential score in the +2 frame (relative to the GP5 CDS).
For illustrative purposes the M CDS, and the GP4 CDS in PRRSV-NA, were not included in the null-model CDS annotations so
that these CDSs, like ORF5a, register positive coding potential (i.e. scores above the dashed line) in the MLOGD analysis. Note
that, regardless of sign (positive or negative), the MLOGD signal tends to be weaker within regions of high conservation (e.g.
within ORF5a) due tothere beingfewersubstitutions with whichto discriminate between the nullmodelandthe alternative model.
A dashed vertical line indicates the 39 end of the common ORF5a variant (46 codons instead of 51 codons) in PRRSV-NA.
Discovery and function of a novel arterivirus gene
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there is only a single SHFV sequence available, MLOGD
could not be used to test the coding potential of ORF5a in
that virus. Although this analysis was based on the
application of MLOGD to specific ORFs, for illustrative
purposes the MLOGD score in a 15-codon sliding window
in the +2 reading frame (with respect to ORF5) is shown
in Fig. 1(b) for alignments of 127 EAV, 232 PRRSV-NA
and 34 PRRSV-EU sequences (i.e. the available sequences
with coverage of both ORF5 and at least 150 nt of its 59
and 39 flanking sequences). Positive coding signatures are
apparent for ORF5a (and also for the M and GP4 CDSs in
cases where they fall in the +2 reading frame with respect
to the GP5 CDS). Additional alignments were generated
for 224 EAV, 8344 PRRSV-NA and 587 PRRSV-EU
sequences that have full coverage of the GP5 CDS, and
were analysed for conservation at synonymous sites as
described in Firth & Atkins (2009) [see also Simmonds
et al. (2008); see Shi et al. (2010) and Zhang et al. (2010)
for recent PRRSV and EAV phylogenies].E n h a n c e d
conservation at synonymous sites is indicative of overlap-
ping functional elements – either coding or non-coding.
In all three alignments, greatly enhanced conservation was
apparent in the region where ORF5a overlaps the GP5
CDS (Fig. 1b).
The newly discovered ORF5a has 59 codons in EAV, either
51 or 46 codons in PRRSV-NA, 43 codons in PRRSV-EU,
47 codons in LDV and 64 codons in SHFV (Fig. 2c). When
applied to the five representative sequences in Fig. 2(c),
despite there being considerable sequence divergence,
PHOBIUS and SIGNALP 3.0 (Ka ¨ll et al., 2004; Bendtsen et al.,
2004) consistently predict that the ORF5a protein is a type
III membrane protein with a short (5–12 aa) lumenal
domain at its amino terminus, a central signal-anchor/
transmembrane sequence, and a cytosolic carboxy-terminal
domain of 13–31 aa.
Fig. 2. Expression of arterivirus ORF5a. (a) RNA sequence and translation of the EAV ORF5a region, showing the slightly
overlapping GP4 and GP5 genes, and the newly discovered ORF5a that overlaps with both. The TRS for sg RNA5 synthesis
and relevant initiation and termination codons are indicated. Red underscores indicate residues mutated to knock out ORF5a in
mutant D5a-2. (b) Context of the ORF5a (green) and ORF5 (blue) translation initiation codons in five representative arterivirus
sequences, illustrating the potential for leaky scanning being the translation initiation mechanism for the second reading frame
(see text for details). The figure shows that the ORF5a initiation codon is the more upstream in EAV and PRRSV-NA and the
more downstream in the other arteriviruses. The ORF4 termination codon is boxed and the two residues mutated to knock out
EAV ORF5a in mutant D5a-2 are indicated by arrows. (c) Amino acid sequences of the ORF5a proteins of five representative
arterivirus sequences. The position of the putative transmembrane domain, as predicted by PHOBIUS (http://phobius.binf.ku.dk;
Ka ¨ll et al., 2004), is indicated in yellow. The ORF5a protein is predicted to be a type III membrane protein (lumenal amino-
terminal domain, central signal-anchor/transmembrane domain and cytoplasmic carboxy-terminal domain).
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expressed from the same subgenomic mRNA via
leaky scanning
The regions around the ORF5a initiation codon in five
representative arterivirus sequences are shown in Fig. 2(b).
In EAV and PRRSV-NA, the ORF5a AUG codon is 59 of
the ORF5 initiation codon and the TRS for the sg RNA5 is
located sufficiently far upstream to include the ORF5a
AUG codon within that sg mRNA, with no additional
intervening AUG codons (Snijder & Meulenberg, 1998;
Pasternak et al., 2000; Lin et al., 2002). On the other hand,
in PRRSV-EU, LDV and SHFV, the ORF5a AUG codon is
located just a few nucleotides 39 of the ORF5 initiation
codon.
In eukaryotes, the efficiency of translation initiation is
modulated by the identity of the nucleotides surrounding
the initiation codon, with the optimal context (known as
the ‘Kozak consensus sequence’) in mammals involving
mainly a guanine at the +4 position and a purine at the
23 position, where the presence of an adenine at the 23
position is the strongest single indicator of efficient
initiation (Kozak, 2002). When the context of the first
AUG codon on a transcript is suboptimal, efficient leaky
scanning to alternative downstream AUG codons can occur
(Kozak, 2002). Here, neither the ORF5 nor ORF5a
initiation codons have a guanine at the +4 position, but
all five arterivirus ORF5 initiation codons have an adenine
at the 23 position. In contrast, the ORF5a initiation
codons have either a pyrimidine (EAV, PRRSV-NA and
SHFV) or a guanine (PRRSV-EU and LDV) at the 23
position. Thus, in PRRSV-NA and EAV, where the ORF5a
AUG codon is 59, there is the potential for efficient leaky
scanning to the ORF5 initiation codon. In contrast, in
PRRSV-EU, LDV and SHFV, where the ORF5a AUG is 39,
conventional leaky scanning for ORF5a translation may be
expected to be less efficient. However, in these sequences,
the ORF5 and ORF5a AUG codons are very closely spaced
(separated by just 2 or 5 nt) and it has been demonstrated
that, if two AUG codons are separated by less than ~10 nt,
efficient initiation may occur at the downstream AUG
codon, even when the upstream AUG codon is in a strong
context (Matsuda & Dreher, 2006).
The analysis of initiation codons and their context, and
ORF5a length, was extended to all available arterivirus
sequences in GenBank. Some 10800 sequences with full or
partial coverage of the ORF5a/ORF5 region were analysed.
In contrast to the above comparative phylogenetic analyses,
simply counting sequences ignores potential phylogenetic
bias (some clades may be greatly over-represented relative
to others; indeed; clustering the sequences with BLASTCLUST
or CLUSTAL X shows this to be the case). Thus, the following
analysis is more meaningful with respect to the range of
features present rather than to the relative abundances of
those features. Many sequences (including ~90% of the
~9600 available PRRSV-NA sequences) cover ORF5
entirely but have no 59 flanking sequence. Therefore they
do not allow analysis of the upstream ORF5a initiation
codon or its context, but still allow analysis of the presence
or absence of premature termination codons within the
part of ORF5a that overlaps ORF5. Nonetheless 136 EAV,
445 PRRSV-NA, 622 PRRSV-EU, 1 SHFV and 5 LDV
sequences have coverage of the ORF5a initiation site, and
the above-mentioned initiation sites and contexts are very
highly conserved (except that ~63% of PRRSV-EU and
~9% of PRRSV-NA sequences have a guanine instead of an
adenine as the nucleotide at the 23 position of the ORF5
initiation codon context). Similarly, the above-mentioned
ORF5a lengths are highly conserved in those sequences
with full or partial coverage of the ORF5a region, with the
notable exception that PRRSV-NA exhibits two main
forms of differing lengths: a 51 codon version (~26% of
sequences) and a 39-truncated 46-codon version (~74% of
sequences). A very small fraction of sequences were found
to be ORF5a-defective as a result of either premature
ORF5a-frame termination codons or substitutions within
the ORF5a initiation codon. However, these do not
necessarily represent sequences from viable viruses, but
might instead be due to sequencing errors, sequencing of
defective virus sequences or curation errors (e.g. five
sequence records in which non-contiguous GP3 and GP5
sequences appear to have been fused in silico). Indeed,
similar numbers of GP5-defective sequences were found
during the analysis.
To summarize, four completely separate computational
analyses – conservation of an ORF, conservation of a
potential translation mechanism, positive MLOGD coding
signatureanda greatlysuppressedfrequencyofsubstitutions
at ORF5-frame synonymous sites – all pointed to the
existence of a novel coding sequence, ORF5a.
Inactivation of EAV ORF5a expression
dramatically affects virus production
To investigate the biological relevance of ORF5a in the
arterivirus replicative cycle, we used an EAV reverse-genetics
system (van Dinten et al., 1997) to engineer two virus
mutantsinwhich ORF5aexpressionwasinactivated.In both
mutants, D5a-1 and D5a-2, the ORF5a translation initiation
codon was mutated (AUG to ACG; U-11113AC), while in
the second mutant a premature termination codon was
engineered at codon six of ORF5a (G-11128AA). Care was
taken that the mutations introduced were translationally
silent with respect to the overlapping GP4 gene (Fig. 2b).
Following electroporation of in vitro-synthesized full-length
RNA into BHK-21 cells, which are also susceptible to EAV
infection, the phenotype of the ORF5a knockout mutants
was compared with that of the wild-type control. Dual-
labelling immunofluorescence (IF) microscopy for replicase
(nsp3) and N protein was performed to verify comparable
transfection efficiency and monitor the synthesis of genome
and subgenomic mRNA7, respectively (not shown). Viral
RNA synthesis in transfected cells was also analysed by
Northern blot hybridization (not shown). Finally, infectivity
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plaque assay, both after the first cycle (18 h post-transfection)
and following subsequent virus amplification in initially non-
transfected BHK-21 cells.
Both IF microscopy and hybridization analysis of intracel-
lular viral RNA demonstrated that the two ORF5a knock-
out mutants were viable and that their RNA synthesis
could not be distinguished from that of the wild-type
control. However, the analysis of viral progeny released
into the medium of transfected cells revealed that both
ORF5a knockout mutants were seriously crippled.
Compared with the wild-type virus, they showed a
reduction in virus titre of approximately two logs, and a
tiny plaque size (Fig. 3a). Upon analysis of the 40 h post-
transfection harvest of mutant D5a-1, several large plaques
were also observed, suggesting rapid reversion of its single
point mutation to the wild-type sequence, which was
subsequently confirmed by sequence analysis of the ORF5a
region of the progeny virus. However, no reversion was
observed for mutant D5a-2, in which a double point
mutation had been engineered.
Confirmation of the importance of EAV ORF5a in
a second, virulent EAV isolate and in natural host
cells
EAV strains can differ significantly in the severity of the
disease they induce in their natural host (Balasuriya et al.,
2007; Maclachlan et al., 2007). The molecular clone used in
the initial experiments described above (pEAV515, a
derivative of pEAV030; van Dinten et al., 1997) was based
on an EAV isolate that was extensively adapted to cell
culture (.300 passages) and causes very mild clinical signs
upon experimental infection of horses (Balasuriya et al.,
1999). To independently confirm the effect of an ORF5a
knockout in a second EAV isolate, the two ORF5a-
inactivating nucleotide substitutions of mutant D5a-2 were
transferred to a molecular clone (pEAVrVBS) of the
virulent Bucyrus strain (VBS) of EAV, which can cause
severe disease in horses (Balasuriya et al., 2007).
Furthermore, in order to use a more natural host cell than
the BHK-21 cells used above, we transfected the in vitro-
synthesized full-length RNAs into equine pulmonary artery
endothelial cells (EEC; Hedges et al., 2001). Again, in both
virus backbones, the D5a-2 mutant displayed a severely
crippled phenotype, with tiny plaques (Fig. 3b) and
infectivity titres reduced by at least two logs. Thus, this
comparative study independently confirmed that the
expression of ORF5a is critical for efficient EAV amplifica-
tion, irrespective of the background of the molecular clone
and cell type used for analysis.
Partial complementation of the EAV ORF5a
knockout defect in ORF5a-expressing cells
Despite the overwhelming bioinformatic evidence for the
functionality of ORF5a, we wanted to exclude the
possibility that the crippled phenotype of the D5a-2
mutant was due to damaging some unidentified yet
important RNA signal in the EAV genome. To this end,
we investigated whether the infectivity defect could be
complemented in a cell line expressing the ORF5a protein.
In view of previous success in rescuing EAV structural-
protein knockouts in BHK-21 cells containing alphavirus











Fig. 3. (a) Comparison of plaque morphology on BHK-21 cells of
wild-type EAV and ORF5a knockout mutant D5a-2, illustrating the
severely crippled phenotype of the latter. In addition to the
dramatically reduced plaque size, D5a-2 infectivity titres were
reduced by approximately two logs. (b) Comparison of wild-type
and D5a-2 plaque morphology on equine endothelial (EEC) cells
using both a cell-culture-adapted EAV isolate (EAV515) and an
isolate that is virulent in horses (VBS). In both virus backbones,
D5a-2 plaque sizes and titres are severely reduced compared with
those of the corresponding parental virus.
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expression vector (Agapov et al., 1998). BHK-21 cells were
transfected with the EAV ORF5a-expressing SinRep19
replicon and positive selection was applied by adding
puromycin to the culture medium. BHK-21 cells contain-
ing a SinRep19 replicon that expresses GFP (SinRep19–
GFP; Agapov et al., 1998; Zevenhoven-Dobbe et al., 2004)
were used as a negative control.
Plaque assays of wild-type and D5a-2 virus were performed
in both the ORF5a- and GFP-expressing cell cultures.
While no difference in plaque size was observed for wild-
type virus (not shown), the D5a-2 virus plaque size was
clearly increased in ORF5a-expressing cell cultures (Fig. 4).
A growth curve experiment in which GFP- and ORF5a-
expressing cells were infected with D5a-2 mutant virus
showed that the D5a-2 titre increased up to fivefold in the
ORF5a-expressing cells (data not shown). Complete
complementation to wild-type plaque size and titre could
not be achieved, which may be due to a variety of technical
or intrinsic factors such as expression level, but these
experiments clearly demonstrated that the expression of
the ORF5a protein directly influences the EAV life cycle.
The ORF5a protein: the eighth structural protein
of arteriviruses?
In this study, we present evidence for the presence,
conservation and biological significance of a previously
unrevealed short CDS in the 39-proximal domain of all
arterivirus genomes. Much like the case of the arterivirus E
and GP2 genes, whose translation is assumed to be initiated
following leaky scanning of the 59-proximal domain of sg
mRNA2 (Snijder et al., 1999), ORF5a and the overlapping
GP5 gene are also likely to be expressed from a functionally
bicistronic sg mRNA. Another striking similarity with the
E–GP2 gene pair (Snijder et al., 1999) is the fact that the
ORF5a initiation codon precedes the GP5 gene in some
arteriviruses (EAV and PRRSV-NA), but is just down-
stream of the ORF5 initiation codon in the others. This
observation raises interesting questions about the evolution
of this part of the arterivirus genome, in particular when
evolving optimal sg mRNA synthesis and the expression
levels of each of the viral structural proteins are taken into
account. In EAV, a 10 nt segment starting with the ORF5
initiation codon can now be assumed to encode amino
acids for three different proteins, GP4, the ORF5a protein
and GP5, in three different reading frames, which again
illustrates the pressure on RNA viruses to compress
maximal coding information into a minimal sequence.
Previous attempts to engineer EAV-based vectors might,
unknowingly, have been affected by the presence of ORF5a.
For example, in one construct the overlap between ORF4
and ORF5 was removed to create an insertion site for
foreign sequences (de Vries et al., 2000). This was achieved
by using a 24 nt insertion that, fortuitously, now proves to
be exactly in-frame with ORF5a, although in the ORF5a
protein it introduces the substitution of Asp-12 for Ala and
Tyr-15 with the sequence Cys-Glu-Leu-Lys-Gln-His-Ala-
Val-His. In view of the reported wild-type phenotype of
this recombinant virus (de Vries et al., 2000), this drastic
change appears to be tolerated. Similarly, after passaging in
cell culture 70 times, a spontaneous insertion of 12 nt into
ORF5a (Ala-Arg-Ser-Leu inserted after the amino-terminal
Met-Phe) of PRRSV-NA was tolerated (Han et al., 2009).
In contrast, derivatives of the EAV-based vector in which
the 24 nt-sequence served to insert additional foreign
sequences, encoding e.g. GFP (de Vries et al., 2001) or
ectodomains of other arterivirus GP5 proteins (Dobbe
et al., 2001), must have suffered because of the disruption
of ORF5a. In fact, the instability and crippled or non-viable
phenotypes reported for some of these constructs could (in
part) be explained by a lack of expression of a functional
ORF5a protein.
The lack of sequence similarity with the contents of protein
databases, the protein sequence plasticity described above
and the limited sequence conservation among arteriviruses
(Fig. 2c) make it difficult to postulate a function for the
ORF5a protein. Its expression from the 39-proximal
domain of the genome, and the apparent lack of an effect
of ORF5a inactivation on viral RNA synthesis, would
suggest that the protein is an additional virion component,
and its hydrophobicity profile would place it in the virus
envelope. On the other hand, knockouts of the other seven
structural-protein genes were lethal to the virus, suggesting
that the ORF5a protein belongs to a different functional
category. Unfortunately, several attempts to raise antisera
using synthetic peptides representing sequences from the
Δ5a-2 Δ5a-2 Wild type
BHK-SinRep19_ORF5a BHK-SinRep19_ORF5a BHK-SinRep19_GFP
Fig. 4. Complementation of the EAV ORF5a
knockout mutant D5a-2 in ORF5a-expressing
cells. The D5a-2 small-plaque phenotype (left)
was partially complemented when the plaque
assay was performed using BHK-21 cells
carrying an ORF5a-expressing SINV RNA repli-
con (middle; Agapov et al., 1998). As a negative
control, cells carrying a GFP-expressing replicon
were used. The plaque morphology of wild-type
virus on ORF5a-expressingcells is shown on the
right.
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unsuccessful, thus obstructing our efforts to directly
analyse virus particles for the presence of the ORF5a
protein or analyse its subcellular localization in the infected
cell. We used the SINV replicon system to express ORF5a
proteins with epitope tags (haemagglutinin- or myc-tags at
either the amino or carboxy terminus), but the D5a-2
mutant virus was no longer complemented by these fusion
proteins. Finally, we were unable to demonstrate the
presence of the ORF5a protein in virions by mass
spectrometric analysis of purified EAV. However, a recent
proteomics analysis of purified PRRSV-NA did identify
several peptides from the ORF5a protein of the porcine
arterivirus, and follow-up studies confirmed both the
expression of the novel protein in infected cells and the
production of antibodies recognizing the PRRSV ORF5a
protein in infected swine (Johnson et al., 2011). Thus, the
combined data now obtained for PRRSV-NA and EAV
strongly suggest that the ORF5a protein is the eighth
structural protein of the arterivirus particle, although more
extensive studies will be required to gain detailed insight
into its function in arterivirus biology.
METHODS
Computational analysis. Virus sequences were obtained from
GenBank initially in Feb 2007 and again in Nov 2010. Arterivirus
nucleotide sequences with coverage of the ORF5 region were
identified by applying NCBI TBLASTN (Altschul et al., 1990) to the
GP5 amino acid sequences from the five reference sequences shown in
Fig. 2(b). In total one SHFV, five LDV, 435 EAV and 10359 PRRSV
sequences with full or partial coverage of ORF5 were retrieved.
PRRSV sequences were separated into PRRSV-NA and PRRSV-EU
genotypes (with respect to GP5), based on the TBLASTN results. Using a
76% cut-off threshold on the TBLASTN ‘maximum identity’ score, all
but eight of the 10359 sequences were cleanly separated between the
two genotypes. Within each group, ORF5 sequences were translated,
aligned and back-translated to nucleotide sequence alignments using
EMBOSS and CLUSTAL (Rice et al., 2000; Larkin et al., 2007). Flanking
nucleotide sequences, where available, were similarly extracted,
aligned and combined into the alignments. Patent sequences and
constructs were removed prior to analysis, and sequences annotated
as defective (found by using the search terms ‘non-functional’,
‘truncated’ and ‘defective’ in GenBank records) were inspected and
removed from the analyses where appropriate. MLOGD statistics were
calculated as described by Firth & Brown (2006). The synonymous
site conservation statistic was calculated as described by Firth &
Atkins (2009). Prior to these latter two analyses: (i) sequences with
premature termination codons in ORF5 or ORF5a were also removed
as being presumed-defective sequences (these amount to ,1% of
sequences and are not obviously clustered phylogenetically), (ii) one
EAV sequence with nine ambiguous nucleotide codes – indicative of
poor sequence quality – was removed and (iii) since there was no
shortage of PRRSV-NA sequences, PRRSV-NA sequences with any
ambiguous nucleotide codes (~10% of sequences) were removed.
Cells and plaque assays. EEC cells (Hedges et al., 2001) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM;
Mediatech) with 110 mg l
-1 sodium pyruvate, 10% FBS (HyClone;
Thermo Scientific), 100 U penicillin ml
-1 and 100 mg streptomy-
cin ml
-1 (Invitrogen), and 200 mM L-glutamine. BHK-21 cells
(ATCC CCL10) were grown in Eagle’s minimum essential medium
with 10% ferritin-supplemented bovine calf serum and 100 U
penicillin ml
-1 and 100 mgs t r e p t o m y c i nm l
-1.P l a q u ea s s a y so nB H K -
21 cells were performed for 3–5 daysas described previously (Nedialkova
et al., 2010), whereas EEC cells were overlaid with DMEM containing
0.75% carboxymethyl cellulose and incubated for 4 days.
Engineering of EAV ORF5a knockout mutants and reverse
genetics. ORF5a knockout mutants D5a-1 and D5a-2 (Fig. 2b) were
created as follows: point mutations were introduced in an appropriate
shuttle vector by standard site-directed PCR mutagenesis
(QuikChange Site-Directed Mutagenesis kit; Agilent Technologies).
Using suitable restriction sites, the desired mutations in the ORF5a-
coding sequence were transferred into EAV full-length cDNA clone
pEAV515 or into pEAVrVBS, an infectious cDNA clone of the
virulent Bucyrus strain of EAV (Balasuriya et al., 2007). pEAV515 is a
derivative of the EAV cDNA clone pEAV030 (van Dinten et al., 1997),
in which the BglII site at position 5217 in ORF1a was knocked out by
using a translationally silent substitution. EAV515 virus has a wild-
type phenotype, as determined by comparison with pEAV030-derived
virus in growth-curve experiments and plaque assays. BHK-21 or EEC
cells were electroporated with in vitro-synthesized full-length RNA
transcripts of wild-type and mutant cDNA clones as described
previously (van Dinten et al., 1997). For IF assays, cells were seeded
on coverslips, paraformaldehyde-fixed and double labelled for EAV
nsp3 and N protein as described by van der Meer et al. (1998).
Analysis of revertants was done by infecting fresh BHK-21 cells with
supernatant harvested at 40 and 72 h post-transfection. Total RNA
was isolated after 24 h by using TRIzol (Invitrogen) and the ORF5a
region was amplified by RT-PCR and sequenced using standard
protocols.
Generation of ORF5a-expressing BHK-21 cells. The coding
sequence of ORF5a was PCR amplified using sense primer E1036
(CGTACGCGTCCATGGGGTTCTTTTACGACTGGTACGTTG; MluI
site underlined) and antisense primer E1037 (CGTGCATGCTCA-
TATCGCAGCAAATTGGCAATA; SphI site underlined), and cloned
between the MluI and SphI sites of the pSinRep19 multiple cloning site
(Agapov et al., 1998). To obtain EAV ORF5a-expressing BHK-21 cells
(BHK-SinRep19–ORF5a), in vitro-transcribed SinRep19–ORF5a RNA
was transfected and puromycin selection (5 mgm l
21) was applied from
24 h post-transfectiononwards.A SinRep19 vectorexpressingGFPwas
used to produce a control cell line (BHK-SinRep19–GFP).
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